Rhinitus/Sinusitis/Ocular Allergy News

Increased concentrations of air pollutants and meteorological changes were associated with numbers of outpatient visits for allergic rhinitis, according to a letter published in Allergy.

Patients with allergic rhinitis and allergy symptoms, particularly nasal symptoms, faced challenges in academic productivity, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Children who ate more fiber had reduced odds for allergic rhinitis and sensitization to specific airborne and food allergens through early adulthood, according to a study published in Clinical and Translational Allergy.

Olopatadine hydrochloride and mometasone furoate nasal spray is now available in the United States for the treatment of symptoms associated with seasonal allergic rhinitis in patients aged 12 years and older, according to a press release.

The effectiveness of different modalities for delivering intranasal topical corticosteroids in treating chronic rhinosinusitis with nasal polyps varied, according to a review published in The Journal of Allergy and Clinical Immunology.

Self-reported anaphylaxis in adults appeared positively associated with the number of allergic diseases they had, according to a study published in Clinical and Translational Allergy.

The nasal spray GSP301 effectively treated symptoms of seasonal allergic rhinitis in children aged 6 to 11 years with a positive impact on their quality of life, according to a study published in Annals of Allergy, Asthma & Immunology.

Patients with rhinitis and rhinosinusitis frequently suffered from comorbidities that imposed a significant burden on outpatient care, according to a study published in Clinical and Translational Allergy.

Temperature-controlled radiofrequency neurolysis of the posterior nasal nerve improved the symptom burden of chronic rhinitis compared with a sham procedure, according to a study published in International Forum of Allergy & Rhinology.

Patients with previous sinus surgery for severe chronic rhinosinusitis with nasal polyps experienced less risk for further surgery while taking mepolizumab compared with placebo, according to a study published by Allergy.